The Patent Finder

Terms ending in 2038

Sanofi

Every in-force patent on Sanofi's record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 11,156,601In Vitro Neonatal Biomimetic (NMIMIC) Model and Methods of Using Same
In force
 · High confidence
Sanofi Pasteur Vaxdesign CorporationIn forceHigh confidence
US 12,630,617Serum Albumin Binders
In force
 · High confidence
SanofiIn forceHigh confidence
US 11,242,384Anti-Tgf-Beta Antibodies and Their Use
In force
 · High confidence
SanofiIn forceHigh confidence
US 12,151,081Medicament Delivery System
In force
 · Medium confidence
SanofiIn forceMedium confidence
US 11,116,832Modification of Engineered Influenza Hemagglutinin Polypeptides
In force
 · High confidence
Sanofi Vaccines US Inc.In forceHigh confidence
US D976,921Display Panel Portion with a Graphical User Interface
In force
 · High confidence
Sanofi US Services Inc.In forceHigh confidence
US 10,538,567Compounds as Peptidic Trigonal GLP1/GLUCAGON/GIP Receptor Agonists
In force
 · High confidence
SanofiIn forceHigh confidence
US 10,626,169Multispecific binding molecules having specificity to dystroglycan and laminin-2
In force
 · High confidence
SanofiIn forceHigh confidence
US 12,454,555Engineered Influenza Antigenic Polypeptides and Immunogenic Compositions Thereof
In force
 · High confidence
Sanofi Vaccines US Inc.In forceHigh confidence
US 10,392,366Azetidine Compounds as GPR119 Modulators for the Treatment of Diabetes, Obesity, Dyslipidemia and Related Disorders
In force
 · High confidence
SanofiIn forceHigh confidence
71 more term ends in 2038 · Pro
10 of 81 patents shown. Soonest term end first, then patent number.
Pro members see all 81.
Upgrade to Pro
73 of these are in force and held by Sanofi.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited